NASDAQ: IOBTIo Biotech Inc Stock Ownership - Who owns Io Biotech?
Insider buying vs selling
Have Io Biotech Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Devin Whittemore Smith | General Counsel | 2024-12-23 | 12,000 | $0.81 | $9.72kBuy |
| Maibritt Zocca | Chief Executive Officer | 2024-12-23 | 12,500 | $0.81 | $10.13kBuy |
| Amy Sullivan | Chief Financial Officer | 2024-12-23 | 10,250 | $0.83 | $8.49kBuy |
| Qasim Iftikhar Ahmad | Chief Medical Officer | 2024-12-23 | 31,350 | $0.85 | $26.55kBuy |
| Holdings A. Novo | 10% Owner | 2024-07-26 | 23,478 | $1.31 | $30.78kSell |
| Holdings A. Novo | 10% Owner | 2024-07-25 | 51,522 | $1.33 | $68.32kSell |
| Holdings A. Novo | 10% Owner | 2024-05-10 | 658,809 | $1.22 | $802.43kSell |
IOBT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IOBT insiders and whales buy or sell their stock.
IOBT Shareholders
What type of owners hold Io Biotech Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Invest A. Lundbeckfond | 21.18% | 13,950,686 | $12.40M | Insider |
| Christian E. Elling | 21.18% | 13,950,686 | $12.40M | Insider |
| Vivo Capital IX LLC | 13.95% | 9,188,984 | $8.17M | Insider |
| Vivo Capital LLC | 9.37% | 6,173,439 | $5.49M | Institution |
| Holdings A. Novo | 6.61% | 4,354,449 | $3.87M | Insider |
| Novo Holdings A | 5.09% | 3,354,449 | $2.98M | Institution |
| Jack Nielsen | 4.58% | 3,015,545 | $2.68M | Insider |
| Hbm Healthcare Investments Cayman Ltd | 4.08% | 2,690,545 | $2.39M | Insider |
| Pfm Health Sciences LP | 3.55% | 2,341,107 | $2.08M | Institution |
| Marshall Wace LLP | 3.20% | 2,105,262 | $1.87M | Institution |
IOBT vs Biotech Stocks
Io Biotech Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.